Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy

Objective: To explore the value of nuclear magnetic resonance (NMR) and functional assessments for follow-up of ambulatory and nonambulatory patients with Duchenne muscular dystrophy (DMD). Methods: Twenty-five 53-skippable patients with DMD were included in this study; 15 were nonambulatory at baseline. All patients underwent clinical and functional assessments every 6 months using the Motor Function Measure (MFM), hand grip and key pinch strength, MoviPlate, and NMR spectroscopy and imaging studies. Results: Upper limb distal strength decreased in nonambulatory patients over the period of 1 year; ambulatory patients showed improvement during the same period. The same applied for several NMRS indices, such as phosphocreatine/adenosine triphosphate, which decreased in older patients but increased in younger ambulatory patients. Fat infiltration in the upper limbs increased linearly with age. Almost all NMR and functional assessment results correlated. Conclusions: Our results underscore complementarity of functional and NMR assessments in patients with DMD. Sensitivity to change of various indices may differ according to disease stage.

[1]  L. Servais,et al.  Non-Ambulant Duchenne Patients Theoretically Treatable by Exon 53 Skipping have Severe Phenotype , 2015, Journal of neuromuscular diseases.

[2]  J. Mendell,et al.  Reliability and validity of active‐seated: An outcome in dystrophinopathy , 2015, Muscle & nerve.

[3]  Ruzena Bajcsy,et al.  Upper extremity 3‐dimensional reachable workspace analysis in dystrophinopathy using Kinect , 2015, Muscle & nerve.

[4]  L. Servais,et al.  Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy , 2015, NMR in biomedicine.

[5]  Jean-Yves Hogrel,et al.  Grip strength measured by high precision dynamometry in healthy subjects from 5 to 80 years , 2015, BMC Musculoskeletal Disorders.

[6]  L. Servais,et al.  Upper Limb Evaluation and One-Year Follow Up of Non-Ambulant Patients with Spinal Muscular Atrophy: An Observational Multicenter Trial , 2015, PloS one.

[7]  P. Carlier,et al.  Validation of a generic approach to muscle water T2 determination at 3T in fat‐infiltrated skeletal muscle , 2015, Journal of magnetic resonance imaging : JMRI.

[8]  L. Servais,et al.  Upper Limb Strength and Function Changes during a One-Year Follow-Up in Non-Ambulant Patients with Duchenne Muscular Dystrophy: An Observational Multicenter Trial , 2015, PloS one.

[9]  C. Senesac,et al.  Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series , 2015, Physical Therapy.

[10]  R. Kotin,et al.  Forelimb treatment in a large cohort of dystrophic dogs supports delivery of a recombinant AAV for exon skipping in Duchenne patients. , 2014, Molecular therapy : the journal of the American Society of Gene Therapy.

[11]  R. Finkel,et al.  Examination of effects of corticosteroids on skeletal muscles of boys with DMD using MRI and MRS , 2014, Neurology.

[12]  W. Triplett,et al.  Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: Effects of age and disease progression , 2014, Neuromuscular Disorders.

[13]  M. Versluis,et al.  Quantitative MRI and strength measurements in the assessment of muscle quality in Duchenne muscular dystrophy , 2014, Neuromuscular Disorders.

[14]  Elizabeth Vroom,et al.  Development of the Performance of the Upper Limb module for Duchenne muscular dystrophy , 2013, Developmental medicine and child neurology.

[15]  R. Finkel,et al.  Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopy. , 2013, Radiology.

[16]  M. Reijnierse,et al.  Comparison of dixon and T1‐weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients , 2013, Journal of magnetic resonance imaging : JMRI.

[17]  B. Wong,et al.  Analysis of fatty infiltration and inflammation of the pelvic and thigh muscles in boys with Duchenne muscular dystrophy (DMD): grading of disease involvement on MR imaging and correlation with clinical assessments , 2013, Pediatric Radiology.

[18]  O. Bieri,et al.  Quantitative MRI and loss of free ambulation in Duchenne muscular dystrophy , 2013, Journal of Neurology.

[19]  W. Triplett,et al.  T2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross‐sectional study of lower leg muscles in 5–15‐year‐old boys with Duchenne muscular dystrophy , 2013, NMR in biomedicine.

[20]  T. Voit,et al.  Innovative methods to assess upper limb strength and function in non-ambulant Duchenne patients , 2013, Neuromuscular Disorders.

[21]  A. Goyenvalle,et al.  Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[22]  N. Azzabou,et al.  Comprehensive longitudinal characterization of canine muscular dystrophy by serial NMR imaging of GRMD dogs , 2012, Neuromuscular Disorders.

[23]  P. Carlier,et al.  Splitting of Pi and other 31P NMR anomalies of skeletal muscle metabolites in canine muscular dystrophy , 2012, NMR in biomedicine.

[24]  J. Hogrel,et al.  Stature is an essential predictor of muscle strength in children , 2012, BMC Musculoskeletal Disorders.

[25]  M. Gaeta,et al.  Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments , 2012, Skeletal Radiology.

[26]  B. Tseng,et al.  Lower leg muscle involvement in Duchenne muscular dystrophy: an MR imaging and spectroscopy study , 2012, Skeletal Radiology.

[27]  C. Senesac,et al.  Relationships of thigh muscle contractile and non-contractile tissue with function, strength, and age in boys with Duchenne muscular dystrophy , 2012, Neuromuscular Disorders.

[28]  E. Mercuri,et al.  Muscle histology vs MRI in Duchenne muscular dystrophy , 2011, Neurology.

[29]  Krista Vandenborne,et al.  Age-related differences in lower-limb muscle cross-sectional area and torque production in boys with Duchenne muscular dystrophy. , 2010, Archives of physical medicine and rehabilitation.

[30]  Bernard J. Dardzinski,et al.  T2 mapping in Duchenne muscular dystrophy: distribution of disease activity and correlation with clinical assessments. , 2010, Radiology.

[31]  U. Sharma,et al.  Effect of creatine monohydrate in improving cellular energetics and muscle strength in ambulatory Duchenne muscular dystrophy patients: a randomized, placebo-controlled 31P MRS study. , 2010, Magnetic resonance imaging.

[32]  J. Fermanian,et al.  Monitoring changes and predicting loss of ambulation in Duchenne muscular dystrophy with the Motor Function Measure , 2010, Developmental medicine and child neurology.

[33]  Fabiana Luisa Mattar,et al.  Hand weakness in Duchenne muscular dystrophy and its relation to physical disability , 2008, Neuromuscular Disorders.

[34]  A. Connolly,et al.  Compositional analysis of muscle in boys with Duchenne muscular dystrophy using MR imaging , 2005, Skeletal Radiology.

[35]  A L Hull,et al.  Assessment of hand function in Duchenne muscular dystrophy. , 1993, Archives of physical medicine and rehabilitation.

[36]  P. Zaniol,et al.  31P-NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers Altered rate of phosphate transport , 1992, Journal of the Neurological Sciences.

[37]  B. Chance,et al.  31P NMR studies in Duchenne muscular dystrophy , 1987, Neurology.

[38]  D. Wilkie,et al.  Muscle energy metabolism in duchenne dystrophy studied by 31P‐NMR: Controlled trials show no effect of allopurinol or ribose , 1985, Muscle & nerve.

[39]  G K Radda,et al.  Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. , 1982, British medical journal.

[40]  Ishu Arpana,et al.  T 2 mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases : a cross-sectional study of lower leg muscles in 5 – 15-year-old boys with Duchenne muscular dystrophy , 2013 .

[41]  Vicente Gilsanz,et al.  Three-point technique of fat quantification of muscle tissue as a marker of disease progression in Duchenne muscular dystrophy: preliminary study. , 2008, AJR. American journal of roentgenology.